EBS

Emergent BioSolutions Inc. is a global life sciences company focused on providing medical countermeasures and life-saving vaccines against chemical, biological, radiological, nuclear, and emerging infectious disease threats. The company develops, manufactures, and delivers products including anthrax vaccines, smallpox treatments, and therapeutics for botulism and other bioterror agents. Emergent gained prominence during the COVID-19 pandemic through vaccine manufacturing partnerships. The company serves both government and commercial markets worldwide.